IMS MAXIMS to Showcase Proven Dementia Software at Major Clinical Conference

IMS MAXIMSIMS MAXIMS will be demonstrating the benefits of their portfolio of user-focused solutions, including innovative dementia software, to a major clinical audience at the Acute and General Medicine conference in London, 27 - 28th November.

Delegates to the conference, which is expected to attract thousands of senior consultants over the two days, will have the opportunity to speak to representatives of IMS MAXIMS about how they create products and services that are easily adapted to suit each customer.

Furthermore, IMS MAXIMS representatives will be on stand F24 to talk about the organisation's strong track record of involving healthcare professionals at every stage of the development process, ensuring their needs and those of patients are given the highest priority.

This approach was clearly evident, as IMS MAXIMS customer Royal Cornwall Hospitals NHS Trust became one of the first in the country to exceed all its Commissioning Quality for Innovation (CQUIN) targets for dementia care. Using IMS MAXIMS' dementia software, developed based on The Department of Health's CQUIN requirements, the trust is now able to more effectively identify patients with dementia and other causes of cognitive impairment to enable a better referral process, reduced length of stays in hospital and effective follow-up care.

Frazer Underwood, associate director of nursing, Royal Cornwall Hospitals NHS Trust said: "The high profile of our dementia work in Cornwall means that the ability of IMS MAXIMS to contribute meaningfully to improving services is invaluable. We felt really engaged with IMS MAXIMS throughout the development process; they were driven by patient needs, delivering a system which put clinical requirements first."

In addition, IMS MAXIMS will also demonstrate its Patient Administration System (PAS), Electronic Patient Record (EPR) and Integrated Care Pathway solutions.

The MAXIMS PAS currently supports more than 11 million patient records in England and a further two million records in Ireland. The system allows healthcare professionals to replace paper-based systems with electronic records that are fast, efficient and accurate, helping both clinical and admin staff work more efficiently while improving patient safety.

The EPR enables a single, complete electronic patient record to be created that contains all relevant information about every aspect of the patient's care - historic notes, all correspondence, past and future appointments and care detail. Whilst the IMS MAXIMS Integrated Care Pathways allows clinicians to easily co-ordinate multiple care actions in a patient-centered approach, allowing care to be delivered efficiently and as quickly as possible.

Shane Tickell, CEO, IMS MAXIMS added: "The Acute and General Medicine conference provides us with an excellent platform to highlight our dementia module and other software solutions. We are committed to developing systems that support healthcare professionals to safely deliver the right care to patients at the right time. In this way, not only do we contribute to improving outcomes for patients but we also help healthcare organisations as they strive to address the multiple challenges that the NHS faces."

IMS MAXIMS will be exhibiting on stand F24; delegates are invited to come along to find out more about the company's current range of clinical healthcare information solutions.

About the Acute and General Medicine conference
Now in its second year the Acute and General Medicine conference (AGM) is expected to be attended by over 4,000 hospital doctors and NHS managers. The AGM programme allows doctors to follow their learning needs across the medical specialties with pacey, interactive seminars, uniquely offering knowledge and skills training in acute and general medicine.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

IMS MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with minimum effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...